These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12640090)

  • 1. Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease.
    Kelada SN; Costa-Mallen P; Checkoway H; Viernes HA; Farin FM; Smith-Weller T; Franklin GM; Costa LG; Longstreth WT; Furlong CE; Jarvik GP; Swanson PD
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):546-7. PubMed ID: 12640090
    [No Abstract]   [Full Text] [Related]  

  • 2. No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population.
    Wang J; Liu Z
    Mov Disord; 2000 Nov; 15(6):1265-7. PubMed ID: 11104219
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease.
    Kondo I; Yamamoto M
    Brain Res; 1998 Sep; 806(2):271-3. PubMed ID: 9739148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson's disease.
    Akhmedova SN; Yakimovsky AK; Schwartz EI
    J Neurol Sci; 2001 Mar; 184(2):179-82. PubMed ID: 11239953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease.
    Carmine A; Buervenich S; Sydow O; Anvret M; Olson L
    Mov Disord; 2002 Jul; 17(4):764-6. PubMed ID: 12210872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gln --> Arg 191 polymorphism of paraoxonase and Parkinson's disease.
    Akhmedova S; Anisimov S; Yakimovsky A; Schwartz E
    Hum Hered; 1999 Jun; 49(3):178-80. PubMed ID: 10364684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to letter to the editor: Paraoxonase genes and the susceptibility to ischemic stroke.
    Liu H
    Int J Stroke; 2014 Apr; 9(3):E7. PubMed ID: 24636586
    [No Abstract]   [Full Text] [Related]  

  • 8. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population.
    Taylor MC; Le Couteur DG; Mellick GD; Board PG
    J Neural Transm (Vienna); 2000; 107(8-9):979-83. PubMed ID: 11041276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations.
    Leviev I; James RW
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):516-21. PubMed ID: 10669651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the human paraoxonase (PON1) promoter.
    Brophy VH; Hastings MD; Clendenning JB; Richter RJ; Jarvik GP; Furlong CE
    Pharmacogenetics; 2001 Feb; 11(1):77-84. PubMed ID: 11207034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients.
    Leviev I; Kalix B; Brulhart Meynet MC; James RW
    Diabetologia; 2001 Sep; 44(9):1177-83. PubMed ID: 11596674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.
    Belin AC; Ran C; Anvret A; Paddock S; Westerlund M; Håkansson A; Nissbrandt H; Söderkvist P; Dizdar N; Ahmadi A; Anvret M; Willows T; Sydow O; Galter D
    Neurosci Lett; 2012 Jul; 522(1):30-5. PubMed ID: 22704918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
    Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H
    Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.
    Araki S; Makita Y; Canani L; Ng D; Warram JH; Krolewski AS
    Diabetologia; 2000 Dec; 43(12):1540-3. PubMed ID: 11151764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
    Clarimon J; Eerola J; Hellström O; Tienari PJ; Singleton A
    Neurosci Lett; 2004 Sep; 367(2):168-70. PubMed ID: 15331145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insecticides and atherosclerosis.
    Luft FC
    J Mol Med (Berl); 2001 Aug; 79(8):415-6. PubMed ID: 11511970
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenomic considerations of the paraoxonase polymorphisms.
    Furlong CE; Cole TB; Jarvik GP; Costa LG
    Pharmacogenomics; 2002 May; 3(3):341-8. PubMed ID: 12052142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort.
    Pascale E; Passarelli E; Purcaro C; Vestri AR; Fakeri A; Guglielmi R; Passarelli F; Meco G
    Acta Neurol Scand; 2011 Sep; 124(3):176-81. PubMed ID: 20880267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.
    Voetsch B; Benke KS; Panhuysen CI; Damasceno BP; Loscalzo J
    Arch Neurol; 2004 Mar; 61(3):351-6. PubMed ID: 15023811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.